We provide innovative soft-tissue reconstruction solutions

that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy.

The hernia repair industry is shifting away from dated synthetic mesh—and for good reason. Hear from Antony Koblish, TELA Bio Co-founder and Chief Executive Officer, on what inspired the development of OviTex—and what it means for patients.

What Makes Us Unique?

Our growing product portfolio is purposefully designed to leverage the patient’s natural healing response while minimizing long-term exposure to permanent synthetic materials. We are committed to delivering our advanced technologies with a strong economic value proposition to assist surgeons and institutions in providing next-generation soft-tissue repair solutions to more patients.

Hernia and Abdominal
Wall Reconstruction

OviTex^® Reinforced
Tissue Matrix

OviTex^® Reinforced Tissue Matrix is composed of ovine forestomach (OFM) that provides a unique functional extracellular matrix (ECM) and a proprietary polymer embroidery, which provides an alternative to permanent and resorbable synthetic mesh. OviTex significantly reduces plastic in the body while enhancing strength and durability at the repair site. With minimal polymer reinforcement and a design that supports natural healing and tissue remodeling, OviTex empowers surgeons to advance hernia repair and improve patient outcomes and quality of life.¹

View The OviTex Portfolio

Plastic & Reconstructive

OviTex^® PRS Reinforced
Tissue Matrix

Experience the only biologic reinforced with interwoven polymer suture designed specifically for plastic and reconstructive surgery. Our next generation reinforced biologic is purposefully designed for consistency in stretch, permeability and handling while facilitating functional remodeling.²

The OviTex PRS portfolio provides multiple resorption, stretch and shape offerings to meet the unique needs of each patient.

View the OviTex PRS Portfolio

Innovation Driven by Expertise

From the outset, TELA Bio’s co-founders, Dr. Maarten Persenaire and Antony Koblish, understood the importance of forming an elite management team to revolutionize the surgical soft-tissue repair market. Today, our leadership team, rich in MedTech experience, brings together decades of industry-specific and diverse expertise, driving innovation in soft-tissue repair.

Learn More About The Team